↓ Skip to main content

Dove Medical Press

Article Metrics

Augmentation with antidepressants in schizophrenia treatment: benefit or risk

Overview of attention for article published in Neuropsychiatric Disease and Treatment, March 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source
twitter
2 tweeters

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
104 Mendeley
Title
Augmentation with antidepressants in schizophrenia treatment: benefit or risk
Published in
Neuropsychiatric Disease and Treatment, March 2015
DOI 10.2147/ndt.s62266
Pubmed ID
Authors

Ming-Dao Zhang, Ye-Meng Mao

Abstract

We focused on the application of antidepressants in schizophrenia treatment in this review. Augmentation of antidepressants with antipsychotics is a common clinical practice to treat resistant symptoms in schizophrenia, including depressive symptoms, negative symptoms, comorbid obsessive-compulsive symptoms, and other psychotic manifestations. However, recent systematic review of the clinical effects of antidepressants is lacking. In this review, we have selected and summarized current literature on the use of antidepressants in patients with schizophrenia; the patterns of use and effectiveness, as well as risks and drug-drug interactions of this clinical practice are discussed in detail, with particular emphasis on the treatment of depressive symptoms in schizophrenia.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 103 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 20%
Student > Master 13 13%
Student > Doctoral Student 12 12%
Researcher 11 11%
Student > Ph. D. Student 10 10%
Other 16 15%
Unknown 21 20%
Readers by discipline Count As %
Medicine and Dentistry 34 33%
Pharmacology, Toxicology and Pharmaceutical Science 13 13%
Psychology 10 10%
Agricultural and Biological Sciences 5 5%
Neuroscience 5 5%
Other 8 8%
Unknown 29 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2020.
All research outputs
#5,124,862
of 18,679,853 outputs
Outputs from Neuropsychiatric Disease and Treatment
#697
of 2,739 outputs
Outputs of similar age
#66,112
of 243,129 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#19
of 45 outputs
Altmetric has tracked 18,679,853 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 2,739 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,129 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.